The United States market has experienced a positive trend, rising 1.2% over the last week and climbing 24% in the past year, with earnings anticipated to grow by 15% annually in the coming years. In ...

The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics ... when it was cleared by the FDA for sickle cell disease (SCD). The UK was the first country to give the go-ahead ...

Access to these treatments is provided under the terms of an interim commercial agreement reached between Vertex and NHS England ... To find out more about what an IFR is, watch our short animation.

Goldman Sachs said it reiterated Buy ratings on OneStream ( NASDAQ: OS ), Vertex ( NASDAQ: VERX) and Workiva ( NYSE: WK) ...

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.” ...

Vertex Pharmaceuticals beat expectations for revenue but missed on earnings. The company has two recent FDA approvals and several treatments in late-stage trials. The core CF treatments make up ...

The Zacks Consensus Estimate for Vertex’s fourth-quarter 2024 earnings is pegged at 14 cents per share, implying a year-over-year increase of 7.7%. Vertex’s earnings surpassed the Zacks ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations , with sales up 15.7% year on year to $2.91 billion. The company ...

In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Vertex (VERX – Research Report), with a price ...

Morgan Stanley analyst Chris Quintero maintained a Buy rating on Vertex (VERX – Research Report) today and set a price target of $57.00. The ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

The watch industry never stops ticking. Keep time with the most exciting new releases from G-Shock, Timex, Citizen and more.